ALBUQUERQUE, NM / ACCESSWIRE / May 29, 2024 / Indica Labs, the global leader in AI-powered digital pathology solutions, announced today the release of the transformative new version of its industry ...

Oct 13 (Reuters) - Agilent Technologies said on Tuesday it would acquire pathology software maker Proscia for $240 million in ...

The digital pathology market is driven by increased teleconsultations, increased usage of digital pathology to improve lab efficiency, and its application in drug discovery and companion diagnostics.

Grundium announced it has acquired Visiopharm to create an integrated precision pathology platform that combines digital slide scanning with AI-driven pathology software. The transaction marks a major ...

Agilent Technologies is buying up the digital pathology software company Proscia in an all-cash transaction valued at $240 ...

PHILADELPHIA--(BUSINESS WIRE)--Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next generation of its flagship Concentriq® platform to help the ...

Agilent Technologies has agreed to acquire Proscia, a provider of digital pathology software for clinical and life sciences customers, in an all-cash transaction valued at $240 million at closing plus ...

<?xml encoding="utf-8" ?> Agilent Technologies Inc. A stock edged higher in Wednesday’s premarket trading after the company ...

PHILADELPHIA--(BUSINESS WIRE)--Proscia®, a leading provider of AI-enabled digital pathology solutions, has made available the Concentriq Dx® digital pathology software for use in reviewing and ...

Agilent Technologies to acquire pathology software company, Proscia for $240 million: Santa Clara, California Thursday, October 15, 2026, 10:00 Hrs [IST] Agilent Technologies Inc.

Leica Biosystems today announced significant upgrades to the APiQ laboratory software solutions system extending it to Android devices and reagents from any vendor. Leica Biosystems’ APiQ – Anatomic ...

Not long after Paige cinched FDA clearance for its algorithm to flag potentially cancerous lesions, another digital pathology startup is touting the results of a study claiming its deep learning ...